The current prices are delayed, login to your account for live prices
Login

Logo

BROACH LIFECARE HOSPITAL LIMIT Share Price

544231
₹ 17.88
+0.00 (0.00%)
1D
Last updated 19 May, 2026, 11:38 IST
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target

--
0.00% up in 1Day
--
1D LOW
1D HIGH
Open
--
High
--
Low
--
Prev. close
17.88

Circuit
L
H
₹14.31
₹21.45
52-week
L
H
₹12.4
₹25.5

Shareholder Returns

Share Price History

Mkt Cap Cr
10.85

P/E
127.71

P/B
1.15

ROE
0.92%

D/E
0

ROCE
2.64%

Div. Yield

EPS(TTM)
0.14
Turnover

EV/EBITDA
0

Net Margin
0%

Op. Margin
0%

ROA
0%

Quick Ratio
0

Curr. Ratio
3.09
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Step 1 of 5
Valuation
Overvalued

Financials

Full statement

Consolidated - Yearly
All values are in INR Crore
Consolidated
Annually
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
16.99
6000
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 6000
Buy orders: 0%
Sell orders: 100%
Bearish
3
Neutral
3
Bullish
2
Slightly Bearish
Indicator
Value
Verdict

RSI (14)
62.45
Neutral

ATR (14)
1.18
Neutral

STOCH(9,6)
100
Bearish

STOCH RSI (14)
89.21
Bearish

ADX(9)
17.8
Bullish

UO(9)
56.06
Neutral

ROC(12)
36.38
Bullish

WillR(14)
-5.06
Bearish
Period
Simple value
Exponential vaue

5D
16.55
16.74

10D
16.58
16.37

20D
15.43
16.21

50D
17.84
14.31

100D
18.29
0
About BROACH LIFECARE HOSPITAL LIMIT
BROACH LIFECARE HOSPITAL LIMIT logo
NSE Symbol
BSE Symbol
BSE: 544231
ISIN
INE0SFZ01018
Sector Market Cap
₹ 10.85 Cr

Broach Lifecare Hospital Limited is an India-based company, which operates its boutique hospitals under the brand, Maple Hospitals. The Company also provides round-the-clock services to patients with heart ailments, consisting of non-invasive cardiology services, such as two-dimensional (2D) echocardiography, electrocardiography, treadmill test, Holter monitoring, ambulatory blood pressure measurement, stress test and dobutamine stress echocardiography. The Company conducts interventional procedures, such as angiography, angioplasty, pacemaker implantation, cardiac resynchronization therapy, arrhythmia management, peripheral angiography, as well as peripheral angioplasty and congenital heart disease interventions. The Company also conducts complex intervention procedures like using cutter balloons for in-stent blockages, implanting drug-eluting balloons in previously implanted stents, fractional flow reserve and rotablator technology for hard calcified blockages.

Frequently Asked Questions